+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Psoriasis Drugs Market Research Reports

Phototherapies for Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Phototherapies for Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Psoriasis Vulgaris - Epidemiology Forecast to 2032 - Product Thumbnail Image

Psoriasis Vulgaris - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Moderate to Severe Plaque Psoriasis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Moderate to Severe Plaque Psoriasis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Coal Tar Topical Solution Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030 - Product Thumbnail Image

Coal Tar Topical Solution Market Outlook Report - Industry Size, Trends, Insights, Market Share, Competition, Opportunities, and Growth Forecasts by Segments, 2022 to 2030

  • Report
  • September 2023
  • 146 Pages
  • Global
From
Japan Psoriasis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Psoriasis Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
India Dexamethasone Market, Competition, Forecast & Opportunities, 2019-2029 - Product Thumbnail Image

India Dexamethasone Market, Competition, Forecast & Opportunities, 2019-2029

  • Report
  • October 2023
  • 71 Pages
  • India
From
Psoriasis Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Psoriasis Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 173 Pages
  • Global
From
Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type (Biologics v/s Biosimilars), By Product Type, By Therapeutic Area, By Distribution Channel, By End Users, By Region, Forecast & Opportunities, 2028 - Product Thumbnail Image

Adalimumab Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type (Biologics v/s Biosimilars), By Product Type, By Therapeutic Area, By Distribution Channel, By End Users, By Region, Forecast & Opportunities, 2028

  • Report
  • December 2022
  • 116 Pages
  • Global
From
HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

HUMIRA (Adalimumab) Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Plaque Psoriasis Treatment Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Plaque Psoriasis Treatment Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Infliximab Drug Market - Global Forecast Report 2023-2031 - Product Thumbnail Image

Infliximab Drug Market - Global Forecast Report 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Psoriasis Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Type; By Route Of Administration; and By Region - Product Thumbnail Image

Psoriasis Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Type; By Route Of Administration; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Plaque Psoriasis (Psoriasis Vulgaris) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • November 2023
  • 1203 Pages
  • Global
From
Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • January 2023
  • 1469 Pages
  • Global
From
Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Plaque Psoriasis - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 108 Pages
  • Global
From
Plaque Psoriasis - Epidemiology Forecast to 2030 - Product Thumbnail Image

Plaque Psoriasis - Epidemiology Forecast to 2030

  • Report
  • September 2021
  • 34 Pages
  • Global
From
US Psoriasis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Psoriasis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
Global Psoriasis Clinical Trial Pipeline Highlights - 2022 - Product Thumbnail Image

Global Psoriasis Clinical Trial Pipeline Highlights - 2022

  • Report
  • August 2022
  • Global
From
Loading Indicator

The Psoriasis Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat psoriasis, a chronic skin condition. Psoriasis is characterized by red, scaly patches on the skin, and can cause itching, burning, and pain. Psoriasis drugs are designed to reduce inflammation, reduce the rate of skin cell growth, and reduce the severity of symptoms. The Psoriasis Drugs market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include AbbVie, Amgen, Celgene, Janssen, and Novartis. These companies offer a range of treatments, including topical creams, oral medications, and biologic drugs. Other companies in the market include Sun Pharmaceuticals, Glenmark Pharmaceuticals, and Lupin Pharmaceuticals. Show Less Read more